- Home
- VKTX vs FIZZ Comparison
VKTX vs FIZZ Comparison
Compare VKTX & FIZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VKTX | FIZZ |
|---|---|---|
| Founded | 2012 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 3.3B |
| IPO Year | 2014 | 1994 |
Fundamental Metrics
Financial Performance| Metric | VKTX | FIZZ |
|---|---|---|
| Price | $35.00 | $30.69 |
| Analyst Decision | Strong Buy | Strong Sell |
| Analyst Count | 7 | 1 |
| Target Price | ★ $95.86 | $35.00 |
| AVG Volume (30 Days) | ★ 2.2M | 655.9K |
| Earning Date | 04-29-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.96 |
| Revenue | N/A | ★ $1,180,552,000.00 |
| Revenue This Year | N/A | $0.14 |
| Revenue Next Year | N/A | $3.33 |
| P/E Ratio | ★ N/A | $15.66 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $22.96 | $30.01 |
| 52 Week High | $43.15 | $47.47 |
Technical Indicators
Market Signals| Indicator | VKTX | FIZZ |
|---|---|---|
| Relative Strength Index (RSI) | 46.82 | 43.34 |
| Support Level | $33.65 | $30.66 |
| Resistance Level | $36.77 | $35.84 |
| Average True Range (ATR) | 1.80 | 0.97 |
| MACD | -0.66 | 0.03 |
| Stochastic Oscillator | 11.83 | 29.50 |
Price Performance
Historical ComparisonAbout VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About FIZZ National Beverage Corp.
National Beverage Corp is a non-alcoholic beverage company in the U.S. Its portfolio skews toward functional drinks (that is those purporting to offer health benefits) and is anchored by the popular LaCroix sparkling water trademark. Other offerings include Rip It energy drinks, Everfresh juices, and soda brands like Shasta and Faygo. The firm controls the majority of its production and distribution apparatus, with very little outsourcing. In terms of go-to-market, it uses warehouse distribution for retailers, direct-store delivery for convenience stores and other small outlets, and food-service distributors for the food-service channel (schools, hospitals, restaurants).